2014
DOI: 10.15326/jcopdf.1.1.2014.0128
|View full text |Cite
|
Sign up to set email alerts
|

The Launch of a New COPD Journal

Abstract: For personal use only. Permission required for all other uses.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 7 publications
0
2
0
Order By: Relevance
“…Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation ( JCOPDF) was launched in May 2014 as the first nonprofit, open-access journal focused on COPD. 6 Under the leadership of founding Editor-in-Chief James D. Crapo, MD, (2014−2020), and current Editor-in-Chief Mark T. Dransfield, MD, (2020−present), this peerreviewed medical/scientific journal includes an editorial board comprised of the world's leading COPD experts. In 10 years, the JCOPDF has interacted with over 2500 COPD researchers and accepted manuscripts from 31 countries.…”
Section: Chronic Obstructive Pulmonary Diseases: Journal Of the Copd ...mentioning
confidence: 99%
See 1 more Smart Citation
“…Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation ( JCOPDF) was launched in May 2014 as the first nonprofit, open-access journal focused on COPD. 6 Under the leadership of founding Editor-in-Chief James D. Crapo, MD, (2014−2020), and current Editor-in-Chief Mark T. Dransfield, MD, (2020−present), this peerreviewed medical/scientific journal includes an editorial board comprised of the world's leading COPD experts. In 10 years, the JCOPDF has interacted with over 2500 COPD researchers and accepted manuscripts from 31 countries.…”
Section: Chronic Obstructive Pulmonary Diseases: Journal Of the Copd ...mentioning
confidence: 99%
“…The mission of the Foundation is to help millions of people live longer and healthier lives by advancing research, advocacy, and awareness to stop chronic obstructive pulmonary disease (COPD), bronchiectasis, and nontuberculous mycobacterial (NTM) lung disease. 5 Over the last 20 years, the COPDF has concentrated not only on the need for enhanced research, including the development of a COPD-specific medical journal, 6 but also on increasing awareness and advocacy, providing education for patients, family members, health care providers, and providing a vehicle for the patient voice (Figure 3). In addition, the COPDF has been a leader in bronchiectasis and NTM lung disease, which is found in up to 30% of COPD patients, 7,8 and developed the first patient research registry for patients with bronchiectasis and NTM lung disease.…”
mentioning
confidence: 99%